latest news releases from the newsroom
Chitwood & Harley
Chitwood & Harley LLP Announces Securities Fraud Suit Against Cerner Corporation for Purchasers of Cerner Securities Between January 23, 2003 And April 2, 2003 -- CERN
ATLANTA, April 4, 2003 (PRIMEZONE) -- Chitwood & Harley LLP announces that a class action lawsuit is pending in the United States District Court for the Western District of Missouri, against Cerner Corporation, ("Cerner" or the "Company"), (Nasdaq:CERN). The suit was filed on behalf of purchasers of the publicly traded securities of Cerner Corp. between January 23, 2003 and April 2, 2003, inclusive ("Class Period").
VI Group plc
VI Group Plc Preliminary Results for the Year Ended 31st December 2002
STROUD, GLOUCESTERSHIRE, United Kingdom, April 4, 2003 (PRIMEZONE) -- VI Group Plc. ("VI" or "the Company") (AMEX:GVI) (LSE:VIG), one of the leading software providers to the mold and die industry, today announces another year of significant growth in its revenues for the year ended 31st December 2002. Profits have been impacted by the investments made in acquiring a new product line during the year and other investments designed to position the Company for future growth, but are ahead of recent expectations.
MoneyTV, Week of 4/4
LOS ANGELES, April 4, 2003 (PRIMEZONE) -- MoneyTV is the nationally syndicated television program all about money and what makes it happen, (http://www.moneytv.net), featuring informative interviews with CEOs, insights into their operations and outlooks for their futures.
Medpharma plc agrees to Further Development with Biora AB
STOCKHOLM, Sweden, April 4, 2003 (PRIMEZONE) -- Biora AB and Medpharma plc (UK) have reached a settlement concerning their dispute regarding their license agreement for development and commercialization of the Xerostomia (dry mouth) project. Medpharma has also committed to further developing with Biora, the Xerostomia product through phase II clinical trials.
AdZone Research, Inc.
AdZone Research Files Form 8-K Saying that 80% of S-8 Shares Recently Approved by Directors Will be Reserved Until Significant Revenues are Achieved by the Company
CALVERTON, N.Y., April 4, 2003 (PRIMEZONE) -- In a Form 8-K filed yesterday with the SEC, the Board of Directors of AdZone Research, Inc. (OTCBB:ADZR) reported passing a resolution to reserve 80% of S-8 stock it approved last week for future compensation to officers, directors and employees. The Board said it took this action to correct misconceptions in the investment community that there would be immediate potential market dilution from issuance of the shares, and that 80% of the shares, or 6 million of the 7.5 million authorized for possible issuance later in the year, would not, in fact, be issued until the company had achieved significant revenues.